文献速递牙周病口腔修复与种植

牙周炎病史者实验性种植体周黏膜炎与牙龈炎的临床、免疫及微生物学评价

Clinical, immunological and microbiological evaluation of experimental peri-implant mucositis and gingivitis in subjects with Grade C, stage III/IV periodontitis background.
PubMed 文献 · J Clin Periodontol · 2023-11-08

本研究比较有牙周炎背景(Grade C、III/IV期)者与牙周健康者在实验性种植体周黏膜炎和牙龈炎中的临床、免疫及微生物学变化。结果显示两组临床炎症表现无显著差异,但牙周炎背景者种植体周围促炎细胞因子浓度较低,且种植体与牙位微生物组存在显著差异,提示牙周病史可调节宿主对生物膜积聚的免疫反应。

要点

  • 牙周炎病史者与健康者实验性黏膜炎/牙龈炎的临床严重程度和消退无显著差异。
  • 牙周炎病史者种植体周围IL-1B、IL-4、IL-17、TNF-α和IFN-γ浓度低于健康者。
  • 种植体周围炎症背景始终高于牙位,且种植体与牙位微生物组显著不同。

核心结论

  • 不同微生物群变化参与牙和种植体周围炎症反应的发生与进展。
  • 牙周病史可调节种植体周和牙周组织对生物膜积聚的免疫反应。

研究设计与样本

  • Pilot研究,比较牙周炎背景者(H-GAP,Grade C、III/IV期)与牙周健康者(H-Health)。
  • 每组n=10,在单个螺丝固位种植体和一对侧牙位诱导实验性黏膜炎/牙龈炎。
  • 受试者停止口腔卫生21天,随后专业预防和卫生指导21天。
  • 基线、诱导期(7、14、21天)和缓解后(42天)收集临床、免疫(多重组分析)和微生物(16S rRNA基因测序)数据。

主要发现

  • 临床参数在两组间(p > .05,Mann-Whitney检验)及位点类型间(p > .05,Wilcoxon检验)于炎症发生和消退时均无显著差异。
  • H-GAP组种植体周围IL-1B、IL-4、IL-17、TNF-α和IFN-γ浓度在基线和黏膜炎诱导期低于H-Health组(p < .05,Mann-Whitney检验)。
  • 两组中种植体在基线和后续所有访视时的炎症背景均显著高于牙位(p < .05,Wilcoxon检验)。
  • 微生物Alpha和Beta多样性在黏膜炎/牙龈炎诱导和消退期间显著变化(p < .05,Shannon和Bray-Curtis指数的限制最大似然法)。
  • H-Health与H-GAP组间牙周和种植体周微生物组分别比较无显著差异,但各时间点种植体周微生物组与牙周微生物组显著不同。

临床怎么用

  • 牙周炎病史者种植体周免疫反应可能不同,需关注其种植体周炎症管理。
  • 种植体周炎症背景高于牙位,提示种植体周维护应更积极。

局限性

  • pilot研究样本量小、检验效能低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To compare individuals with a periodontitis background (Grade C, stage III/IV-formerly generalized aggressive periodontitis) (H-GAP) with periodontally healthy subjects (H-Health) in terms of molecular changes (immunological/microbiological) accompanying experimental peri-implant mucositis and gingivitis. MATERIALS AND METHODS: H-GAP and control (H-Health) subjects were recruited, and experimental mucositis/gingivitis was induced around a single screw-retained implant and one contralateral tooth. Participants refrained from oral hygiene for 21 days in the selected areas, followed by professional prophylaxis and hygiene instructions for 21 days. Clinical parameters, immunological markers (multiplex analysis) and microbial data (16S rRNA gene sequencing) were collected at baseline, during induction (7, 14 and 21 days) and following remission (42 days). RESULTS: Clinically, no significant differences were observed between the groups (n = 10/each group) (H-GAP vs. H-Health) (p > .05, Mann-Whitney test) and the type of site (tooth vs. implant) (p > .05, Wilcoxon test) at the time of onset and resolution, or severity of gingival/mucosal inflammation. H-GAP displayed lower concentrations of the cytokines interleukin (IL)-1B, IL-4, IL-17, tumor necrosis factor-α and interferon-γ around implants than H-Health at baseline and during induction of mucositis (p < .05, Mann-Whitney test). In both groups, implants showed significantly higher inflammatory background at baseline and all subsequent visits when compared with teeth (p < .05, Wilcoxon test). Alpha and β-diversity metrics showed a significant shift in the microbiome composition and abundances of core species during induction and resolution of peri-implant mucositis and gingivitis (p < .05, restricted maximum likelihood method of Shannon and Bray-Curtis indices, respectively). Differences were not significant for these parameters between the H-Health and H-GAP groups when the periodontal and peri-implant microbiomes were compared separately; however, at each time point, the peri-implant microbiome differed significantly from the periodontal microbiome. CONCLUSIONS: Within the limitations of this pilot study (e.g. low power), it can be concluded that different microbial shifts contribute to the onset and progression of inflammatory responses around teeth and implants and that history of periodontal disease experience plays an additional role in modulating the immune response of peri-implant and periodontal tissues to biofilm accumulation.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Dutra TP, Freitas Monteiro M, França-Grohmann IL, et al. Clinical, immunological and microbiological evaluation of experimental peri-implant mucositis and gingivitis in subjects with Grade C, stage III/IV periodontitis background. J Clin Periodontol. 2023. PMID: 37941050. doi:10.1111/jcpe.13896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。